APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurotensin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neurotensin Industry Growth and Trends Forecast to 2032

29 December 202593 pages

Choose your research edition.

Industry ResearchNeurotensin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotensin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotensin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotensin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotensin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neurotensin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurotensin include APExBIO, Bio - Techne, Eurogentec, Genscript, MedChemExpress, Peptide Institute and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neurotensin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neurotensin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurotensin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurotensin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neurotensin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neurotensin Market by Company

APExBIO

Bio - Techne

Eurogentec

Genscript

MedChemExpress

Peptide Institute

PerkinElmer

Neurotensin Segment by Type

Bovine

Canine

Human

Mouse

Neurotensin Segment by Application

Scientific Research

Medical

Others

Neurotensin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotensin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotensin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotensin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurotensin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neurotensin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bovine Table 2. Major Company of Canine Table 3. Major Company of Human Table 4. Major Company of Mouse Table 5. Global Neurotensin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Neurotensin Sales by Type (2021-2026) & (K Units) Table 7. Global Neurotensin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Neurotensin Sales Market Share in Value by Type (2021-2026) Table 10. Global Neurotensin Price by Type (2021-2026) & (US$/Unit) Table 11. Global Neurotensin Sales by Type (2027-2032) & (K Units) Table 12. Global Neurotensin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Neurotensin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Neurotensin Sales Market Share in Value by Type (2027-2032) Table 15. Global Neurotensin Price by Type (2027-2032) & (US$/Unit) Table 16. North America Neurotensin Sales by Type (2021-2026) & (K Units) Table 17. North America Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Neurotensin Sales by Type (2021-2026) & (K Units) Table 19. Europe Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Neurotensin Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Neurotensin Sales by Type (2021-2026) & (K Units) Table 23. Latin America Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Neurotensin Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Neurotensin Sales by Type (2021-2026) & (US$ Million) Table 26. Neurotensin Industry Trends Table 27. Neurotensin Industry Drivers Table 28. Neurotensin Industry Opportunities and Challenges Table 29. Neurotensin Industry Restraints Table 30. Global Neurotensin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Neurotensin Revenue Market Share by Company (2021-2026) Table 32. Global Neurotensin Sales by Company (2021-2026) & (K Units) Table 33. Global Neurotensin Sales Share by Company (2021-2026) Table 34. Global Neurotensin Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Neurotensin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Neurotensin Major Company Production Sites and Headquarters Table 37. Global Neurotensin Company, Product Type & Application Table 38. Global Neurotensin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Neurotensin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Neurotensin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Neurotensin Sales by Region (2021-2026) & (K Units) Table 43. Global Neurotensin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Neurotensin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Neurotensin Sales Market Share in Value by Region (2021-2026) Table 46. Global Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Neurotensin Sales by Region (2027-2032) & (K Units) Table 48. Global Neurotensin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Neurotensin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Neurotensin Sales Market Share in Value by Region (2027-2032) Table 51. Global Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Neurotensin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Neurotensin Sales by Application (2021-2026) & (K Units) Table 54. Global Neurotensin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Neurotensin Sales Market Share in Value by Application (2021-2026) Table 57. Global Neurotensin Price by Application (2021-2026) & (US$/Unit) Table 58. Global Neurotensin Sales by Application (2027-2032) & (K Units) Table 59. Global Neurotensin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Neurotensin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Neurotensin Sales Market Share in Value by Application (2027-2032) Table 62. Global Neurotensin Price by Application (2027-2032) & (US$/Unit) Table 63. North America Neurotensin Sales by Application (2021-2026) & (K Units) Table 64. North America Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Neurotensin Sales by Application (2021-2026) & (K Units) Table 66. Europe Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Neurotensin Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Neurotensin Sales by Application (2021-2026) & (K Units) Table 70. Latin America Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Neurotensin Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Neurotensin Sales by Application (2021-2026) & (US$ Million) Table 73. APExBIO Company Information Table 74. APExBIO Business Overview Table 75. APExBIO Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. APExBIO Neurotensin Product Portfolio Table 77. APExBIO Recent Development Table 78. Bio - Techne Company Information Table 79. Bio - Techne Business Overview Table 80. Bio - Techne Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bio - Techne Neurotensin Product Portfolio Table 82. Bio - Techne Recent Development Table 83. Eurogentec Company Information Table 84. Eurogentec Business Overview Table 85. Eurogentec Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Eurogentec Neurotensin Product Portfolio Table 87. Eurogentec Recent Development Table 88. Genscript Company Information Table 89. Genscript Business Overview Table 90. Genscript Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Genscript Neurotensin Product Portfolio Table 92. Genscript Recent Development Table 93. MedChemExpress Company Information Table 94. MedChemExpress Business Overview Table 95. MedChemExpress Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. MedChemExpress Neurotensin Product Portfolio Table 97. MedChemExpress Recent Development Table 98. Peptide Institute Company Information Table 99. Peptide Institute Business Overview Table 100. Peptide Institute Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Peptide Institute Neurotensin Product Portfolio Table 102. Peptide Institute Recent Development Table 103. PerkinElmer Company Information Table 104. PerkinElmer Business Overview Table 105. PerkinElmer Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. PerkinElmer Neurotensin Product Portfolio Table 107. PerkinElmer Recent Development Table 108. North America Neurotensin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Neurotensin Sales by Country (2021-2026) & (K Units) Table 110. North America Neurotensin Sales Market Share by Country (2021-2026) Table 111. North America Neurotensin Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Neurotensin Sales Market Share Forecast by Country (2027-2032) Table 113. North America Neurotensin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Neurotensin Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Neurotensin Market Share by Country (2021-2026) Table 116. North America Neurotensin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Neurotensin Market Share Forecast by Country (2027-2032) Table 118. Europe Neurotensin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Neurotensin Sales by Country (2021-2026) & (K Units) Table 120. Europe Neurotensin Sales Market Share by Country (2021-2026) Table 121. Europe Neurotensin Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Neurotensin Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Neurotensin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Neurotensin Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Neurotensin Market Share by Country (2021-2026) Table 126. Europe Neurotensin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Neurotensin Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Neurotensin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Neurotensin Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Neurotensin Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Neurotensin Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Neurotensin Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Neurotensin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Neurotensin Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Neurotensin Market Share by Country (2021-2026) Table 136. Asia-Pacific Neurotensin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Neurotensin Market Share Forecast by Country (2027-2032) Table 138. Latin America Neurotensin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Neurotensin Sales by Country (2021-2026) & (K Units) Table 140. Latin America Neurotensin Sales Market Share by Country (2021-2026) Table 141. Latin America Neurotensin Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Neurotensin Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Neurotensin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Neurotensin Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Neurotensin Market Share by Country (2021-2026) Table 146. Latin America Neurotensin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Neurotensin Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Neurotensin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Neurotensin Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Neurotensin Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Neurotensin Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Neurotensin Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Neurotensin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Neurotensin Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Neurotensin Market Share by Country (2021-2026) Table 156. Middle East and Africa Neurotensin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Neurotensin Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Neurotensin Distributors List Table 161. Neurotensin Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Neurotensin Image Figure 2. Global Neurotensin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotensin Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurotensin Sales (2021-2032) & (K Units) Figure 5. Bovine Image Figure 6. Global Bovine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Canine Image Figure 8. Global Canine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Human Image Figure 10. Global Human Sales YoY Growth (2021-2032) & (K Units) Figure 11. Mouse Image Figure 12. Global Mouse Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Neurotensin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Neurotensin Market Share by Type 2025 VS 2032 Figure 15. North America Neurotensin Sales Market Share in Volume by Type in 2025 Figure 16. North America Neurotensin Sales Market Share in Value by Type in 2025 Figure 17. Europe Neurotensin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Neurotensin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Neurotensin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Neurotensin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Neurotensin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Neurotensin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Neurotensin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Neurotensin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Neurotensin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Scientific Research Image Figure 28. Global Scientific Research Sales YoY Growth (2021-2032) & (K Units) Figure 29. Medical Image Figure 30. Global Medical Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Neurotensin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Neurotensin Market Share by Application 2025 VS 2032 Figure 35. North America Neurotensin Sales Market Share in Volume by Application in 2025 Figure 36. North America Neurotensin Sales Market Share in Value by Application in 2025 Figure 37. Europe Neurotensin Sales Market Share in Volume by Application in 2025 Figure 38. Europe Neurotensin Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Neurotensin Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Neurotensin Sales Market Share in Value by Application in 2025 Figure 41. Latin America Neurotensin Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Neurotensin Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Neurotensin Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Neurotensin Sales Market Share in Value by Application in 2025 Figure 45. North America Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Neurotensin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Neurotensin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Neurotensin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Neurotensin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Neurotensin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Neurotensin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Neurotensin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Neurotensin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Neurotensin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Neurotensin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Neurotensin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Neurotensin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Neurotensin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Neurotensin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Neurotensin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Neurotensin Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Neurotensin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine
  • Canine
  • Human
  • Mouse
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • APExBIO
  • Bio - Techne
  • Eurogentec
  • Genscript
  • MedChemExpress
  • Peptide Institute
  • PerkinElmer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurotensin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neurotensin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neurotensin Market by Type
  6. 1.3.1 Bovine
  7. 1.3.2 Canine
  8. 1.3.3 Human
  9. 1.3.4 Mouse
  10. 1.4 Global Neurotensin Market Size by Type
  11. 1.4.1 Global Neurotensin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Neurotensin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Neurotensin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Neurotensin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Neurotensin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Neurotensin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Neurotensin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Neurotensin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neurotensin Industry Trends
  2. 2.2 Neurotensin Industry Drivers
  3. 2.3 Neurotensin Industry Opportunities and Challenges
  4. 2.4 Neurotensin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neurotensin Revenue (2021-2026)
  2. 3.2 Global Top Players by Neurotensin Sales (2021-2026)
  3. 3.3 Global Top Players by Neurotensin Price (2021-2026)
  4. 3.4 Global Neurotensin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurotensin Major Company Production Sites & Headquarters
  6. 3.6 Global Neurotensin Company, Product Type & Application
  7. 3.7 Global Neurotensin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurotensin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurotensin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurotensin Tier 1, Tier 2, and Tier 3
4 Neurotensin Regional Status and Outlook
  1. 4.1 Global Neurotensin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neurotensin Historic Market Size by Region
  3. 4.2.1 Global Neurotensin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neurotensin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neurotensin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neurotensin Forecasted Market Size by Region
  7. 4.3.1 Global Neurotensin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neurotensin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neurotensin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neurotensin by Application
  1. 5.1 Neurotensin Market by Application
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Neurotensin Market Size by Application
  6. 5.2.1 Global Neurotensin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Neurotensin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Neurotensin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Neurotensin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Neurotensin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Neurotensin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Neurotensin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Neurotensin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 APExBIO
  2. 6.1.1 APExBIO Company Information
  3. 6.1.2 APExBIO Business Overview
  4. 6.1.3 APExBIO Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 APExBIO Neurotensin Product Portfolio
  6. 6.1.5 APExBIO Recent Developments
  7. 6.2 Bio - Techne
  8. 6.2.1 Bio - Techne Company Information
  9. 6.2.2 Bio - Techne Business Overview
  10. 6.2.3 Bio - Techne Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bio - Techne Neurotensin Product Portfolio
  12. 6.2.5 Bio - Techne Recent Developments
  13. 6.3 Eurogentec
  14. 6.3.1 Eurogentec Company Information
  15. 6.3.2 Eurogentec Business Overview
  16. 6.3.3 Eurogentec Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eurogentec Neurotensin Product Portfolio
  18. 6.3.5 Eurogentec Recent Developments
  19. 6.4 Genscript
  20. 6.4.1 Genscript Company Information
  21. 6.4.2 Genscript Business Overview
  22. 6.4.3 Genscript Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genscript Neurotensin Product Portfolio
  24. 6.4.5 Genscript Recent Developments
  25. 6.5 MedChemExpress
  26. 6.5.1 MedChemExpress Company Information
  27. 6.5.2 MedChemExpress Business Overview
  28. 6.5.3 MedChemExpress Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MedChemExpress Neurotensin Product Portfolio
  30. 6.5.5 MedChemExpress Recent Developments
  31. 6.6 Peptide Institute
  32. 6.6.1 Peptide Institute Company Information
  33. 6.6.2 Peptide Institute Business Overview
  34. 6.6.3 Peptide Institute Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Peptide Institute Neurotensin Product Portfolio
  36. 6.6.5 Peptide Institute Recent Developments
  37. 6.7 PerkinElmer
  38. 6.7.1 PerkinElmer Company Information
  39. 6.7.2 PerkinElmer Business Overview
  40. 6.7.3 PerkinElmer Neurotensin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PerkinElmer Neurotensin Product Portfolio
  42. 6.7.5 PerkinElmer Recent Developments
7 North America by Country
  1. 7.1 North America Neurotensin Sales by Country
  2. 7.1.1 North America Neurotensin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neurotensin Sales by Country (2021-2026)
  4. 7.1.3 North America Neurotensin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neurotensin Market Size by Country
  6. 7.2.1 North America Neurotensin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neurotensin Market Size by Country (2021-2026)
  8. 7.2.3 North America Neurotensin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neurotensin Sales by Country
  2. 8.1.1 Europe Neurotensin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neurotensin Sales by Country (2021-2026)
  4. 8.1.3 Europe Neurotensin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neurotensin Market Size by Country
  6. 8.2.1 Europe Neurotensin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neurotensin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neurotensin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neurotensin Sales by Country
  2. 9.1.1 Asia-Pacific Neurotensin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neurotensin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neurotensin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neurotensin Market Size by Country
  6. 9.2.1 Asia-Pacific Neurotensin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neurotensin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neurotensin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neurotensin Sales by Country
  2. 10.1.1 South America Neurotensin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neurotensin Sales by Country (2021-2026)
  4. 10.1.3 South America Neurotensin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neurotensin Market Size by Country
  6. 10.2.1 South America Neurotensin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neurotensin Market Size by Country (2021-2026)
  8. 10.2.3 South America Neurotensin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neurotensin Sales by Country
  2. 11.1.1 Middle East and Africa Neurotensin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neurotensin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neurotensin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neurotensin Market Size by Country
  6. 11.2.1 Middle East and Africa Neurotensin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neurotensin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neurotensin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neurotensin Value Chain Analysis
  2. 12.1.1 Neurotensin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neurotensin Production Mode & Process
  7. 12.2 Neurotensin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neurotensin Distributors
  10. 12.2.3 Neurotensin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst